How can lupus nephritis class III, class IV, and class V be distinguished on gross (macroscopic) and microscopic (light, immunofluorescence, and electron) examination of a kidney biopsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Distinguishing Lupus Nephritis Classes III, IV, and V on Kidney Biopsy

The key to distinguishing these classes lies in identifying the pattern and location of immune deposits and the presence or absence of leukocyte infiltration: Class III/IV show subendothelial deposits with leukocyte influx (proliferative), while Class V shows subepithelial deposits without leukocyte influx (membranous). 1

Macroscopic (Gross) Examination

Gross examination of kidney biopsies in lupus nephritis typically shows no distinguishing features between classes III, IV, and V. The kidney may appear normal or show non-specific changes. The diagnosis requires microscopic evaluation with light microscopy (LM), immunofluorescence (IF), and electron microscopy (EM).

Microscopic Examination

Light Microscopy Features

Class III (Focal Lupus Nephritis):

  • <50% of glomeruli affected with active or inactive focal, segmental, or global endocapillary or extracapillary glomerulonephritis
  • Segmental endocapillary hypercellularity is the hallmark feature 2
  • May show fibrinoid necrosis (fibrin with GBM disruption and/or mesangial matrix lysis) 1
  • Active lesions include endocapillary hypercellularity, karyorrhexis, fibrinoid necrosis, wire loops, and cellular crescents

Class IV (Diffuse Lupus Nephritis):

  • ≥50% of glomeruli affected with active or inactive diffuse, segmental, or global endocapillary or extracapillary glomerulonephritis
  • Global endocapillary hypercellularity is characteristic of Class IVG 2
  • Wire loops (thickened capillary walls from subendothelial deposits visible by LM) are hallmarks 2
  • Hyaline thrombi and double contours (basement membrane duplication) are prominent features 2
  • Class IVS shows intermediate characteristics between Class III and IVG 2
  • Note: The 2018 revision eliminated the S/G subdivisions for classification purposes, though these distinctions should still be described 1

Class V (Membranous Lupus Nephritis):

  • Diffuse thickening of glomerular capillary walls
  • No significant endocapillary hypercellularity or leukocyte infiltration 1
  • Basement membrane "spikes" may be visible on silver stains
  • Abundant mesangial deposits distinguish it from primary membranous nephropathy 3

Immunofluorescence Microscopy

Critical distinguishing feature: Location of immune deposits

Class III:

  • Mesangial and peripheral (capillary wall) pattern most common 4
  • IgG, C3, and C1q are typically present
  • "Full house" pattern (IgG, IgA, IgM, C3, C1q) is characteristic of lupus

Class IV:

  • Peripheral (capillary wall) pattern is by far the most common 4
  • Intense granular staining along capillary walls
  • IgG, C3, and C1q predominate
  • Full house pattern frequently present

Class V:

  • Membranous pattern with granular deposits along capillary walls
  • Predominantly subepithelial location
  • May have mesangial deposits as well 3
  • Full house pattern can be present

Electron Microscopy

This is the definitive method for distinguishing classes based on deposit location:

Class III/IV:

  • Subendothelial deposits (between endothelium and basement membrane) are the defining feature 1
  • These deposits are associated with leukocyte influx (neutrophils and monocytes/macrophages) 1
  • Mesangial deposits are also present
  • The subendothelial location is what drives the proliferative response

Class V:

  • Subepithelial deposits (between basement membrane and podocytes) are the defining feature 1
  • No leukocyte influx into capillaries 1
  • Mesangial deposits are typically abundant (unlike primary membranous nephropathy) 3
  • May have intramembranous deposits

Mixed Class III/IV + V:

  • Shows both subendothelial AND subepithelial deposits 1
  • Leukocyte influx is present (from the proliferative component)
  • This combination requires treatment as proliferative disease 3

Practical Algorithm for Classification

  1. First, assess glomerular involvement by LM:

    • <50% glomeruli affected → Consider Class III
    • ≥50% glomeruli affected → Consider Class IV
    • Diffuse capillary wall thickening without proliferation → Consider Class V
  2. Second, perform IF to identify deposit pattern:

    • Peripheral/capillary wall dominant → Class III/IV or V
    • Membranous pattern alone → Class V
  3. Third, use EM to determine deposit location (DEFINITIVE):

    • Subendothelial deposits + leukocyte influx → Class III or IV (based on extent)
    • Subepithelial deposits without leukocyte influx → Class V
    • Both subendothelial and subepithelial → Mixed Class III/IV + V

Common Pitfalls

  • Don't rely on LM alone: Wire loops and hyaline thrombi suggest Class IV, but EM is required for definitive classification
  • Mesangial deposits are present in all classes: Their presence doesn't distinguish between classes
  • Class V can coexist with Class III/IV: Always look for both subendothelial and subepithelial deposits on EM 3
  • Prior steroid treatment reduces deposits: Interpretation must consider treatment history, as steroids reduce subendothelial and mesangial deposits 5
  • Segmental vs. global distinction has poor reproducibility: The 2018 revision eliminated this as a classification criterion for Class IV, though it should still be described 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.